Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vivus appoints two more to board

This article was originally published in Scrip

Executive Summary

Vivus has appointed another two directors to its board, continuing its recent spate of board hirings. The Mountain View, California-based company has appointed J Martin Carroll and Dr Jorge Plutzky. Mr Carroll most recently served at Boehringer Ingelheim in key roles including head of global strategy and development, and president and CEO, US, from 2003-11. Dr Plutzky, a leader in the prevention and treatment of cardiometabolic disease, currently serves as director of the Vascular Disease Prevention Program.

Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC021422

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel